Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Israel journal of medical sciences 1984-May

Accidental tenfold overdose of influenza vaccine: a clinical and serological study.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
H Matzkin
E Nili

Märksõnad

Abstraktne

We analyzed the effects of an accidental tenfold overdose of influenza vaccine that was given to 31 young healthy members of the Israel Defense Forces. A clinical workup and serological tests were performed after the vaccination in order to quantify any side effects or complications and relate them to immunogenicity of the vaccine administered. A small age-matched control group of 20 soldiers of the Israel Defense Forces who received normal doses (0.5 ml) of vaccine was subjected to the same examinations. A low vaccine efficacy was noted with the recommended 0.5-ml dose (7 micrograms of hemagglutinin of each influenza type), shown by low fourfold titer rises. A significantly higher number of fourfold changes was noted, as expected, in the study group that received 5.0 ml. Pre- and postvaccination geometric mean titers (GMT) in the control group for A/Bangkok (H3N2), A/Brazil (H1N1) and B/Singapore rose from 21.42 to 47.56, from 13.89 to 45.74 and from 10.44 to 11.68, respectively. In the study group the elevation was significantly more pronounced, GMT rising from 19.15 to 83.54, from 16.81 to 96.60 and from 10.00 to 18.88, respectively. Some minor reactions, such as headache and general malaise, were observed in both the study and control groups, but were more frequent in the former. No severe immediate or long-term local and systemic side effects were noted in either group. The findings presented emphasize the high safety limits of the vaccine used, but also highlight its poor immunogenicity.

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge